Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dose attenuation through a titanium alloy hip prosthesis.

T Y Eng1

  • 1Department of Radiology, University of Texas Health Science Center at San Antonio, USA. tyeng@pol.net

Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
|April 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling the target dose fall-off in IMRT and VMAT planning techniques for cervical SBRT.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2017
Same author

Rectal and bladder dose reduction with the addition of intravaginal balloons to vaginal packing in intracavitary brachytherapy for cervical cancer.

Brachytherapy·2016
Same author

Dosimetric effect of photon beam energy on volumetric modulated arc therapy treatment plan quality due to body habitus in advanced prostate cancer.

Practical radiation oncology·2015
Same author

Adjuvant radiation therapy for low stage testicular seminoma: Diagnosis and therapy in evolution.

Urologic oncology·2011
Same author

Thymoma: update for the new millennium.

The oncologist·2001
Same author

Two sides are better than one.

International journal of radiation oncology, biology, physics·1998

Titanium hip prostheses significantly reduce radiation dose during pelvic radiotherapy, causing 32-64% attenuation. This dose perturbation requires careful consideration in treatment planning for patients with hip implants, particularly those with prostate cancer.

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Biomedical Engineering

Background:

  • Pelvic irradiation poses challenges due to dose perturbations from medical implants.
  • Hip prostheses, commonly made of titanium alloy, are frequently present in patients undergoing pelvic radiotherapy.
  • Accurate dose calculation is crucial for effective cancer treatment and minimizing side effects.

Purpose of the Study:

  • To quantify the radiation dose attenuation caused by a standard titanium alloy hip prosthesis.
  • To evaluate the impact of varying radiation beam energies and prosthesis thickness on dose reduction.
  • To emphasize the clinical relevance of these findings in radiotherapy treatment planning.

Main Methods:

  • Experimental measurement of radiation dose attenuation.

Related Experiment Videos

  • Utilized a commonly used titanium alloy hip prosthesis.
  • Varied radiation beam energies and measured dose through different prosthesis thicknesses.

    • Main Results:

    • Significant dose attenuation was observed, ranging from 32% to 64%.
    • Attenuation varied based on the incident radiation beam energy.
    • Dose reduction was also dependent on the thickness of the prosthesis encountered by the beam.

    Conclusions:

    • Titanium hip prostheses cause substantial radiation dose perturbation during pelvic irradiation.
    • Treatment planning must account for this attenuation effect, especially in patients with bilateral prostheses.
    • Consideration is critical for prostate cancer patients where the tumor is located between bilateral hip prostheses.